1. Characterization and treatment of spontaneous recurrent seizures following nerve agent-induced status epilepticus in mice.
- Author
-
McCarren HS, Eisen MR, Nguyen DL, Dubée PB, Ardinger CE, Dunn EN, Haines KM, Santoro AN, Bodner PM, Ondeck CA, Honnold CL, McDonough JH, Beske PH, and McNutt PM
- Subjects
- Animals, Disease Models, Animal, Mice, Status Epilepticus chemically induced, Status Epilepticus physiopathology, Anticonvulsants therapeutic use, Levetiracetam therapeutic use, Nerve Agents adverse effects, Phenobarbital therapeutic use, Soman adverse effects, Status Epilepticus diagnosis, Status Epilepticus drug therapy, Valproic Acid therapeutic use
- Abstract
Purpose: To develop and characterize a mouse model of spontaneous recurrent seizures following nerve agent-induced status epilepticus (SE) and test the efficacy of existing antiepileptic drugs., Methods: SE was induced in telemeterized male C57Bl6/J mice by soman exposure, and electroencephalographic activity was recorded for 4-6 weeks. Mice were treated with antiepileptic drugs (levetiracetam, valproic acid, phenobarbital) or corresponding vehicles for 14 d after exposure, followed by 14 d of drug washout. Survival, body weight, seizure characteristics, and histopathology were used to characterize the acute and chronic effects of nerve agent exposure and to evaluate the efficacy of treatments in mitigating or preventing neurological effects., Results: Spontaneous recurrent seizures manifested in all survivors, but the number and frequency of seizures varied considerably among mice. In untreated mice, seizures became longer over time. Moderate to severe histopathology was observed in the amygdala, piriform cortex, and CA1. Levetiracetam provided modest improvements in neurological parameters such as reduced spike rate and improved histopathology scores, whereas valproic acid and phenobarbital were largely ineffective., Conclusions: This model of post-SE spontaneous recurrent seizures differs from other experimental models in the brief latency to seizure development, the occurrence of seizures in 100 % of exposed animals, and the lack of damage to CA4/dentate gyrus. It may serve as a useful tool for rapidly and efficiently screening novel therapies that would be effective against severe epilepsy cases., Competing Interests: Declaration of Competing Interest None., (Published by Elsevier B.V.)
- Published
- 2020
- Full Text
- View/download PDF